z-logo
open-access-imgOpen Access
Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo
Author(s) -
Kazuya Masuda,
Barry Ripley,
Riko Nishimura,
Takashi Mino,
Osamu Takeuchi,
Go Shioi,
Hiroshi Kiyonari,
Tadamitsu Kishimoto
Publication year - 2013
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1307419110
Subject(s) - messenger rna , untranslated region , experimental autoimmune encephalomyelitis , microbiology and biotechnology , autoimmunity , rna binding protein , biology , ribonuclease , rna , in vivo , chemistry , immunology , immune system , gene , biochemistry , genetics
Posttranscriptional regulation of IL-6 has been largely uncharacterized, with the exception of the ribonuclease Regnase-1, which prevents autoimmunity by destabilizing IL-6 mRNA. Here, we identified AT-rich interactive domain-containing protein 5A (Arid5a) as a unique RNA binding protein, which stabilizes IL-6 but not TNF-α mRNA through binding to the 3' untranslated region of IL-6 mRNA. Arid5a was enhanced in macrophages in response to LPS, IL-1β, and IL-6. Arid5a deficiency inhibited elevation of IL-6 serum level in LPS-treated mice and suppressed IL-6 levels and the development of T(H)17 cells in experimental autoimmune encephalomyelitis. Importantly, Arid5a inhibited the destabilizing effect of Regnase-1 on IL-6 mRNA. These results indicate that Arid5a plays an important role in promotion of inflammatory processes and autoimmune diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom